NanoPass Technologies: Funding, Investors & Team (Sep 2026)
NanoPass is where cutting-edge technology intersects with healthcare innovation. We pioneer revolutionary solutions in intradermal delivery, reshaping the landscape of therapeutic and medical aesthetic procedures using our proprietary technology towards a precise, safe, and efficient future. Our MicronJet™ intradermal delivery product platform has redefined the standard of care. Join the Intradermal precision revolution! NanoPass's IP-backed product, the MicronJet (registered with the US FDA, the EU, Brazil, China, Australia and other countries), is the most advanced hollow microneedles device available today. Its excellent performance is backed by more than 50 clinical studies. The Company has concluded the world's first intradermal pandemic flu vaccine study and additional seasonal flu studies, demonstrating equivalent or superior immunogenicity to standard delivery using only 20% of the dose. The company is backed by prominent Israeli and US investors Ă˝and medical device companies, including IHCV, Ofer Hi-Tech, D-Partners, WFD Ventures and Elcam Medical. NanoPass recently closed a new round of financing, led by Israel Health Care Ventures (IHCV) NanoPass is continuously engaged in joint clinical development with top pharmaceutical companies, to demonstrate the benefits of its technology for various indications.
NanoPass Technologies has raised $4.0M across 1 funding round on record, the most recent a Seed of $4.0M announced in Jul 2024.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
NanoPass Technologies Company Profile and Key Stats
Latest funding round on record: Jul 2024.
NanoPass Technologies Funding Rounds
NanoPass Technologies Founders and Leadership Team
Contact details for the NanoPass Technologies team: 1 of 1 has an email address on file.
Start 14-day free trial →NanoPass Technologies Funding Compared to Other Health Care Startups
NanoPass Technologies' latest round of $4.0M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NanoPass Technologies in Health Care and Ness Ziona
Companies Similar to NanoPass Technologies
QuantHealth is an organization that produces software using artificial intelligence technology for drug…
Inspira Technologies is a cutting-edge medical technology company that specializes in the acute respiratory…
Alpha Tau Medical is an Israeli medical device company that focuses on research, development and…
Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma…
Vortex Imaging develops medical imaging devices.
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and…
VISIONIX develops, manufactures and distributes innovative equipment and provides a complete solution for…
Fize Medical is a health care company based in Israel.
Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation,…
TopGum has developed a highly scalable patent-pending delivery system with the capacity to deliver a wide…
Nanox offers the Nanox System as a preventative healthcare Medical Screening As A Service (MSaaS). Nanox…
Microbot Medical is a company that creates innovative medical devices using micro-robotic technology. They…
NanoPass Technologies Funding FAQs
What does NanoPass Technologies do?
NanoPass is where cutting-edge technology intersects with healthcare innovation. We pioneer revolutionary solutions in intradermal delivery, reshaping the landscape of therapeutic and medical aesthetic procedures using our proprietary technology towards a precise, safe, and efficient future. Our MicronJet™ intradermal delivery product platform has redefined the standard of care. Join the Intradermal precision revolution! NanoPass's IP-backed product, the MicronJet (registered with the US FDA, the EU, Brazil, China, Australia and other countries), is the most advanced hollow microneedles device available today. Its excellent performance is backed by more than 50 clinical studies. The Company has concluded the world's first intradermal pandemic flu vaccine study and additional seasonal flu studies, demonstrating equivalent or superior immunogenicity to standard delivery using only 20% of the dose. The company is backed by prominent Israeli and US investors Ă˝and medical device companies, including IHCV, Ofer Hi-Tech, D-Partners, WFD Ventures and Elcam Medical. NanoPass recently closed a new round of financing, led by Israel Health Care Ventures (IHCV) NanoPass is continuously engaged in joint clinical development with top pharmaceutical companies, to demonstrate the benefits of its technology for various indications.
How much funding has NanoPass Technologies raised?
NanoPass Technologies has raised $4.0M across 1 round on record. The most recent is a Seed of $4.0M announced in Jul 2024.
When did NanoPass Technologies last raise funding?
NanoPass Technologies' most recent funding round on record is a Seed of $4.0M, announced in Jul 2024.
Who founded NanoPass Technologies?
FundedIQ lists Daniel Levitats (Founder) at NanoPass Technologies.
Where is NanoPass Technologies headquartered?
NanoPass Technologies is based in Ness Ziona, Hamerkaz, Israel.
How many employees does NanoPass Technologies have?
NanoPass Technologies is in the 11-50 employee band.
How does NanoPass Technologies' funding compare to other Health Care startups?
NanoPass Technologies' latest round of $4.0M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's NanoPass Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NanoPass Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.